December 26, 2017: Markets opened lower Tuesday following the three-day Christmas holiday weekend. The DJIA briefly turned higher, but traded for most of the day with a small loss. Energy was the leading sector but couldn’t overcome weakness in tech and utilities. WTI crude oil for February delivery settled at $59.97 a barrel, up 2.6% for the day following a pipeline explosion in Libya. The is WTI’s highest close in more than two years. February gold added 0.7% on the day to settle at $1,287.50. Equities were headed for a lower �close shortly before the bell as the DJIA traded down 0.11% for the day, the S&P 500 traded down 0.18%, and the Nasdaq Composite traded down 0.41%.
Bitcoin futures for January traded at $15,920, up about 12.6%, on the CME after opening at $13,900 this morning. Only 374 contracts had been traded in the session and open interest is just 489.
The DJIA stock posting the largest daily percentage loss ahead of the close Tuesday was Apple Inc. (NASDAQ: AAPL) which traded down 2.63% at $170.41. The stock’s 52-week range is $114.76 to $177.20. Volume was nearly 10% above the daily average of around 26 million shares. Some analysts said iPhone X sales would be down sharply from quarterly.
Best Gold Stocks To Invest In 2019: Ormat Technologies, Inc.(ORA)
Advisors' Opinion:- [By Scott Levine]
When talk around the water cooler turns to energy investments, it's oil and gas companies that represent the usual suspects. Renewable energy companies like Vestas Wind Systems (NASDAQOTH:VWDRY), First Solar (NASDAQ:FSLR), and Ormat Technologies (NYSE:ORA) -- companies whose names are far less recognizable than those like ExxonMobil and Chevron -- may not be on most investors' radars. However, there are certainly reasons to believe that they should be.
- [By Ethan Ryder]
Orange (EPA:ORA) received a €16.50 ($19.19) price target from Credit Suisse Group in a research note issued to investors on Wednesday. The firm currently has a “buy” rating on the stock. Credit Suisse Group’s price target indicates a potential upside of 17.61% from the stock’s previous close.
- [By Max Byerly]
Orange (EPA:ORA) has been assigned a €20.00 ($24.69) price target by equities researchers at Barclays in a research report issued to clients and investors on Monday. The firm currently has a “buy” rating on the stock. Barclays’ price target indicates a potential upside of 42.55% from the company’s previous close.
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering. Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET. XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday. Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results. Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday. RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday. Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering. Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading. Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements. Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results. CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering - [By Logan Wallace]
Roth Capital set a $67.00 price target on Ormat Technologies (NYSE:ORA) in a report issued on Sunday. The brokerage currently has a buy rating on the energy company’s stock.
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss. Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter. Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter. Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss. Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday. Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share. Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading. Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results. Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday. 51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday
Best Gold Stocks To Invest In 2019: ChannelAdvisor Corporation(ECOM )
Advisors' Opinion:- [By Shane Hupp]
ChannelAdvisor (NYSE: ECOM) and Tyler Technologies (NYSE:TYL) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.
Best Gold Stocks To Invest In 2019: AeroCentury Corp.(ACY)
Advisors' Opinion:- [By Joseph Griffin]
TheStreet downgraded shares of AeroCentury (NYSEAMERICAN:ACY) from a b rating to a c rating in a report issued on Wednesday morning.
Separately, Zacks Investment Research raised shares of AeroCentury from a sell rating to a hold rating in a research note on Monday, February 12th.
- [By Max Byerly]
AeroCentury (NYSEAMERICAN:ACY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “AeroCentury Corp. was formed to acquire JetFleet Aircraft, L.P. and JetFleet Aircraft II, L.P., in a statutory merger. The company is an operating lessor and finance company which specializes in leasing used turboprop aircraft and engines. The company’s aircraft and engines are on lease to regional airlines and commercial users in the U.S., Canada, the U.K., South America and Europe. (PRESS RELEASE) “
Best Gold Stocks To Invest In 2019: ADMA Biologics Inc(ADMA)
Advisors' Opinion:- [By Joseph Griffin]
These are some of the media headlines that may have effected Accern Sentiment Analysis’s scoring:
Get ADMA Biologics alerts: Global Drugs for Respiratory Syncytial Virus (RSV) Market 2018 Insights- Ablynx, AmVac, AlphaVax and ADMA Biologics (exclusivereportage.com) Global Drugs for Respiratory Syncytial Virus (RSV) Market 2018 View- ADMA Biologics, Ablynx, AlphaVax and AmVac (exclusivereportage.com) After-Hours Stock Movers 06/07: (ZUMZ) (DOCU) (SFIX) Higher; (MVIS) (ITI) (ADMA) Lower (more…) (streetinsider.com) Why is the 200 Simple Moving Average (SMA) so common for traders and analysts? Build-A-Bear Workshop, Inc … (thestreetpoint.com) Global Lupus Therapeutic Market 2018 by Players: ADMA Biologics, Amgen, Anthera Pharma, Bayer HealthCare (ebuzzcommunity.com)ADMA has been the subject of a number of analyst reports. Maxim Group set a $10.00 price objective on shares of ADMA Biologics and gave the stock a “buy” rating in a report on Monday, May 14th. ValuEngine raised shares of ADMA Biologics from a “sell” rating to a “hold” rating in a report on Monday, May 14th.
- [By Max Byerly]
Maxim Group set a $10.00 price objective on ADMA Biologics (NASDAQ:ADMA) in a report issued on Monday. The brokerage currently has a buy rating on the biotechnology company’s stock.
- [By Joseph Griffin]
Aevi Genomic Medicine (NASDAQ: GNMX) and ADMA Biologics (NASDAQ:ADMA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends.
Best Gold Stocks To Invest In 2019: (SMPQY)
Advisors' Opinion:- [By ]
I studied the management running the company and found fantastic professionals coming from large institutions like Novartis AG (NYSE:NVS), Sun Pharmaceuticals Industries (OTCPK:SMPQY), AstraZeneca Group plc (NYSE:AZN), or Endo International plc (NASDAQ:ENDP).
Best Gold Stocks To Invest In 2019: Vince Holding Corp.(VNCE)
Advisors' Opinion:- [By Shane Hupp]
Francesca’s (NASDAQ: FRAN) and Vince (NYSE:VNCE) are both small-cap consumer discretionary companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.
- [By Lisa Levin] Gainers Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study. Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing. ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating. Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook. TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy. Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday. Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital. Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00. SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday. Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40. Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins. Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
No comments:
Post a Comment